Ranbaxy Launches Anti-Allergic Nasal Spray (India)
This article was originally published in PharmAsia News
Executive Summary
Indian pharmaceutical major Ranbaxy Laboratories has launched a new nasal spray in India. The spray, called Osonase (ciclesonide), is designed to treat both seasonal and perennial allergies. Osonase is approved for use in both adults and teenagers. The latest edition joins Ranbaxy's lineup of allergy medications. The company has also recently developed a number of delivery mechanisms for asthma treatments, including dry-powder inhalers, and inhalers that use hydro fluoro alkane as an environmentally conscious propellant. (Click here for more